ABASTECIMIENTOS FARMACEUTICOS NOROESTE SL
Company details
- Active NIF/CIF: B86731908
-
-
-
-
Address: Polígono Industrial P-29, Calle Husillo, 41, 28400 Collado Villalba, Madrid, España See in map
-
-
Featured products:
More information on ABASTECIMIENTOS FARMACEUTICOS NOROESTE SL
-
25/09/2014 | BORME act no.: 382496 | Register: MADRIDCeses/Dimisiones
-
25/09/2014 | BORME act no.: 382496 | Register: MADRIDNombramientos
-
18/03/2014 | BORME act no.: 121990 | Register: MADRIDNombramientos
-
25/06/2013 | BORME act no.: 289167 | Register: MADRIDConstitución
-
25/06/2013 | BORME act no.: 289167 | Register: MADRIDNombramientos
-
25/06/2013 | BORME act no.: 289168 | Register: MADRIDNombramientos
Other information
The CIF assigned to ABASTECIMIENTOS FARMACEUTICOS NOROESTE SL is B86731908, and its commercial status is active. The company carries out its operations within the CNAE 4646 - Comercio al por mayor de productos farmacéuticos. Likewise, its SIC code 5122 - Droguería, perfumería y farmacia identifies it.
ABASTECIMIENTOS FARMACEUTICOS NOROESTE SL employs a team of Between 1 and 9 employees and records an annual turnover of between 2 and 10 million euros. The entity is registered in the Mercantile Registry of Madrid and has 4 registration charges. The last announcement in Borme was published on 25/09/2014, while the most recent deposit of ordinary annual accounts is from the year -.
To access the contact information of ABASTECIMIENTOS FARMACEUTICOS NOROESTE SL, such as the phone number, address, or website, visit the Company Data module.
If you require additional information about ABASTECIMIENTOS FARMACEUTICOS NOROESTE SL, you can review one of our available financial reports, the Annual Accounts of the company, or verify its default incidents in the RAI delinquency file.
All the financial, commercial, and legal information we provide about ABASTECIMIENTOS FARMACEUTICOS NOROESTE SL comes from official sources and is regularly updated.
Do you want to know more about ABASTECIMIENTOS FARMACEUTICOS NOROESTE SL??
Find out more about this company by consulting these reports: